Cellebrite director reports initial share and RSU holdings
Cellebrite DI Ltd. director Utsumi Ryusuke filed an initial statement of beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. director Utsumi Ryusuke filed an initial statement of beneficial ownership. He reports direct holdings of 40,795 Ordinary Shares and 10,601 Restricted Stock Units, each representing a right to receive one Ordinary Share. The restricted stock units vest on September 17, 2026, reflecting future potential equity ownership rather than a current share issuance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (2)
- F1. The restricted stock units vest on September 17, 2026.
- F2. Each restricted stock unit represents a contingent right to receive one ordinary share.
AI-generated analysis. How Rhea-AI works. Not financial advice.